Latent and active transforming growth factor β1 released from genetically modified keratinocytes modulates extracellular matrix expression by dermal fibroblasts in a coculture system

Journal of Investigative Dermatology

Volumn 119, Issue 2, 2002, Pages 456-463

  Bauer, Barbara S ^a   Tredget, Edward E ^a   Marcoux, Yvonne ^a   Scott, Paul G ^a   Ghahary, Aziz ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Adenovirus; Coculture; Fibroblasts; Keratinocytes; Transforming growth factor 1

Indexed keywords

COLLAGEN TYPE 1; COLLAGENASE; COMPLEMENTARY DNA; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR; TRANSFORMING GROWTH FACTOR BETA1;

ADENOVIRUS; ARTICLE; CELL FUNCTION; CELL MEMBRANE; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FIBROBLAST; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; KERATINOCYTE; NORTHERN BLOTTING; PRIORITY JOURNAL; RNA ANALYSIS; RNA EXTRACTION;

EID: 0036039929     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2002.01837.x     Document Type: Article

References (48)

1. An assay for transforming growth factor-β using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct
2. Suppression of monocyte function and differential regulation of IL-1 and IL-4 contribute to resolution of experimental arthritis
3. Particle-mediated gene transfer with transforming growth factor-β1 cDNAs enhances wound repair in rat skin
4. Growth factors and wound healing: Part II. Role in normal and chronic wound healing
5. Platelet-derived growth factor in vivo: Levels, activity, and rate of clearance
6. Site-directed mutagenesis of cysteine residues in the pro region of the transforming growth factor β1 precursor: Expression and characterization of mutant proteins
7. Sustained release of epidermal growth factor accelerates wound repair
8. Development, characterization and wound healing of the keratin-14 promoted transforming growth factor-β1 transgenic mice
9. Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases
10. Concerted action of TGF-β1 and its type II receptor in control of epidermal homeostasis in transgenic mice
11. Characterization and autoregulation of latent transforming growth factor beta (TGF-beta) complexes in osteoblast-like cell line: Production of a latent complex lacking the latent TGF-β binding protein
12. Immunodetection of quantitation of the two forms of transforming growth factor-beta (TGF-β1 and TGF-β2) secreted by cells
13. Modulation of transforming growth factor-β1 stimulated elastin and collagen production and proliferation in porcine vascular smooth muscle cells and skin fibroblasts by basic fibroblast growth factor-α, and insulin-like growth factor-1
14. Cellular activation of latent transforming growth factor β requires binding to the cation-independent mannose-6-phosphate/insulin-like growth factor type II receptor
15. Transforming growth factor-beta stimulates the expression of collagenase and metalloproteinase inhibitor
16. Epidermal regulation of dermal fibroblast activity
17. Expression of mRNA for transforming growth factor-β1 is reduced in hypertrophic scar and normal dermal fibroblasts following serial passage in vitro
18. Interferon gamma and alpha-2b differentially regulate the expression of collagenase and TIMP-1 mRNA in human hypertrophic and normal dermal fibroblasts
19. Genetically modified dermal keratinocytes express high levels of transforming growth factor-β1
20. Insulin-like growth factor-II/mannose 6 phosphate receptors facilitate the matrix effects of latent transforming growth factor-β1 released from genetically modified keratinocytes in a fibroblast/keratinocyte co-culture system
21. TGF-β latency: Biological significance and mechanism of activation
22. Transforming growth factor-β1 stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix
23. Autoinduction of transforming growth factor β1 is mediated by the AP-1 complex
24. Exogenous transforming growth factor-beta amplifies its own expression and induces scar formation in a model of human fetal skin repair
25. Growth factors in wound healing
26. Proteolytic activation of latent transforming growth factor-β from fibroblast conditioned medium
27. Mechanism of activation of latent recombinant transforming growth factor-β1 by plasmin
28. Transforming growth factor and forskolin increase all classes of insulin-like growth factor-1 transcripts in normal and human osteoblast-like cells
29. Independent regulation of collagenase, 72 kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-β
30. The activity of collagenase-1 is required for keratinocyte migration of a type I collagen matrix
31. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta
32. The enhancement in wound healing by transforming growth factor-β1 depends on the topical delivery system
33. Identification of mannose 6-phosphate in 2 asparagine-linked sugar chains of recombinant transforming growth factor-β-1 precursor
34. Serial cultivation of strains of human epidermal keratinocytes: The formation of keratinizing colonies from single cells
35. Transforming growth factor type β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro
36. Autocrine induction of tumor protease production and invasion by a metallothionein-regulated TGF-β1
37. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: Activation of a latent transforming growth factor-1-like molecule by plasmin
38. Characterization of the activation of latent TGF-β by co-cultures of endothelial cells and pericytes or smooth muscle cells: A self-regulating system
39. Factors involved in the differetiation of TGF-β-producing cells from niave CD4+ T cells: IL-4 and IFN-γ have opposing effects, while TGF-β positively regulates its own production
40. Inhibition of skin development by overexpression of transforming growth factor β1 in the epidermis of transgenic mice
41. Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-growth inhibitor in serum-free medium
42. Adenovector-mediated gene transfer of active transforming growth factor-β1 induces prolonged severe fibrosis in rat lung
43. Some recent advances in the chemistry and biology of transforming growth factor-β
44. Molecular cloning of the large subunit of transforming growth factor type β masking protein and expression of the mRNA in various rat tissues
45. Transforming growth factor β1 positively regulates its own expression in normal and transformed cells
46. Keratinocyte gene therapy
47. Distribution and modulation of the cellular receptor for transforming growth factor-beta
48. Recombinant latent TGF-β1 has a longer half life in rats than active TGF-β1 and a different tissue distribution